Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 265.64 |
| Open | 267.54 |
| Bid | 263.97 x 100 |
| Ask | 264.12 x 100 |
| Day's range | 263.39 - 268.77 |
| 52-week range | 211.71 - 329.72 |
| Volume | |
| Avg. volume | 2,934,004 |
| Market cap | 141.52B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 21.14 |
| EPS (TTM) | 12.49 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 9.00 (3.41%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | 307.50 |
ZacksAmgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.
PR NewswireAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20, from 9:15-11:15 a.m. PDT.
ZacksAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.